BLTE
Price
$59.55
Change
-$2.59 (-4.17%)
Updated
Jun 13 closing price
Capitalization
1.94B
52 days until earnings call
RAIN
Price
$3.48
Change
+$0.05 (+1.46%)
Updated
Jun 13 closing price
Capitalization
38.19M
Interact to see
Advertisement

BLTE vs RAIN

Header iconBLTE vs RAIN Comparison
Open Charts BLTE vs RAINBanner chart's image
Belite Bio
Price$59.55
Change-$2.59 (-4.17%)
Volume$21.09K
Capitalization1.94B
RAIN ENHANCEMENT TECHNOLOGIES HOLD
Price$3.48
Change+$0.05 (+1.46%)
Volume$3.61K
Capitalization38.19M
BLTE vs RAIN Comparison Chart
Loading...
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BLTE vs. RAIN commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLTE is a StrongBuy and RAIN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 15, 2025
Stock price -- (BLTE: $59.55)
Brand notoriety:
Market capitalization --

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLTE’s FA Score shows that 0 FA rating(s) are green while.

  • BLTE’s FA Score: 0 green, 5 red.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLTE’s TA Score shows that 5 TA indicator(s) are bullish while RAIN’s TA Score has 4 bullish TA indicator(s).

  • BLTE’s TA Score: 5 bullish, 5 bearish.
  • RAIN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, BLTE is a better buy in the short-term than RAIN.

Price Growth

BLTE (@Biotechnology) experienced а -0.22% price change this weekfor the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.75%. For the same industry, the average monthly price growth was +12.94%, and the average quarterly price growth was +4.02%.

Reported Earning Dates

BLTE is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (-0.75% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BLTE($1.94B) has a higher market cap than RAIN($38.2M). RAIN YTD gains are higher at: 187.603 vs. BLTE (-5.626). BLTE has higher annual earnings (EBITDA): -35.42M vs. RAIN (-73.57M). BLTE (0) and RAIN (0) have equivalent revenues.
BLTERAINBLTE / RAIN
Capitalization1.94B38.2M5,073%
EBITDA-35.42M-73.57M48%
Gain YTD-5.626187.603-3%
P/E RatioN/AN/A-
Revenue00-
Total CashN/A77.3M-
Total DebtN/A456K-
TECHNICAL ANALYSIS
Technical Analysis
BLTERAIN
RSI
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
82%
MACD
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BLTE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RAIN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYCFX40.37-0.38
-0.93%
Rydex Biotechnology C
PREIX157.52-1.77
-1.11%
T. Rowe Price Equity Index 500
CHTTX20.39-0.28
-1.35%
AMG River Road Mid Cap Value N
CMIEX13.30-0.21
-1.55%
Multi-Manager Intl Eq Strats Instl
SMEFX17.94-0.29
-1.59%
Invesco Small Cap Equity R6

BLTE and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLTE has been loosely correlated with RAIN. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if BLTE jumps, then RAIN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLTE
1D Price
Change %
BLTE100%
-4.17%
RAIN - BLTE
48%
Loosely correlated
+1.46%
ACOG - BLTE
24%
Poorly correlated
-2.65%
ALEC - BLTE
23%
Poorly correlated
-4.94%
CLDX - BLTE
22%
Poorly correlated
+4.47%
APLS - BLTE
22%
Poorly correlated
-2.23%
More